Skip to content

Development and Feasibility of Mindfulness Based Pain Reduction

Feasibility Clinical Trial of Integrated Mind-Body Therapy for Chronic Low Back Pain

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04980612
Acronym
MBPR
Enrollment
52
Registered
2021-07-28
Start date
2021-12-14
Completion date
2025-05-01
Last updated
2026-07-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Low-back Pain

Keywords

pain, mindfullness, MBSR, Low Back, pain reduction, interoceptive awareness

Brief summary

This is a development study with clinical outcomes. The investigators aim to develop and test an 8-week MBPR (Mindfulness-Based Pain Reduction) program, which draws on intervention work and clinical experience in the investigative team to optimize a mindfulness-based intervention for individuals with chronic pain. The overall goal of this study is to ensure that the MBPR program has been carefully refined and manualized in an in-person setting before performing clinical trials comparing MBPR to MBSR (Mindfulness-Based Stress Reduction) to test whether it improves pain outcomes. This study includes a Pain Attention Task that separates insula activation during experimental heat application between different pain attention conditions.

Detailed description

MBPR will be an optimized mindfulness program specifically designed for treating chronic low back pain (cLBP) that the investigators aim to develop and test in this project. 4 groups of 10 participants will receive MBPR consecutively to refine the MBPR curriculum. The format is the same as MBSR: 8 weeks of weekly 2½-hour group sessions and a daylong retreat. All sessions include training to enhance mindful interoceptive awareness through focused attention in the region of pain, the lower back. A final group of 20 participants will be randomized to receive MBPR or MBSR. Total N=50 (40 MBPR; 10 MBSR). MBSR is a standardized and manualized 8-week program, delivered once a week in 2½-hour group sessions and a daylong retreat. It trains individuals in several mindfulness practices, e.g. focus on breath, varying degrees and directions of object orientation, open monitoring of awareness of intero- and exteroceptive stimuli and thoughts, de-reification (i.e. the notion that thoughts and perceptions are not always true to reality), and meta-awareness (i.e., awareness of thinking) in addition to focused attention. The program typically includes audio-recording and a workbook for home practice and has shown benefits in patients with cLBP. This project also includes an ancillary brain imaging study designed to build on neuroscience reports of markedly decreased brain function and structure in the insular cortex (IC) of patients with cLBP. This project has the potential to reveal a potential central mechanism by which mind-body and acceptance-based approaches improve chronic pain conditions, e.g. cLBP. It may reveal a new paradigm for the treatment of cLBP with key importance and consequences for future behavioral intervention studies for pain.

Interventions

BEHAVIORALMindfulness Based Pain Reduction

40 participants will participate in a MBPR program. It will be an optimized mindfulness program specifically designed for treating cLBP that we will develop and test in this project. The format is the same as MBSR: 8 weeks of weekly 2½-hour group sessions and a daylong retreat.

BEHAVIORALMindfulness Based Stress Reduction

10 participants will participate in MBSR program. MBSR is a standardized and manualized 8-week program, delivered once a week in 2½-hour group sessions and a daylong retreat. It trains individuals in several mindfulness practices, e.g. focus on breath, varying degrees and directions of object orientation, open monitoring of awareness of intero- and exteroceptive stimuli and thoughts, de-reification (i.e. the notion that thoughts and perceptions are not always true to reality), and meta-awareness (i.e., awareness of thinking) in addition to focused attention.The program typically includes audio-recordings and a workbook for home practice and has shown benefits in patients with cLBP.

Sponsors

University of California, San Francisco
Lead SponsorOTHER
National Center for Complementary and Integrative Health (NCCIH)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Intervention model description

The intervention and MBPR manual will be refined iteratively in 4 courses with 10 participants. The last of these 4 MBPR classes will be about 10 of 20 participants randomly assigned to either participate in standard MBSR or MBPR. The first part of the study is single-arm, the last randomized to assess acceptability of randomization.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Chronic low back pain (cLBP) defined according to the NIH Research Task Force recommendation on Research Standards for cLBP: pain at least half the days in the past 6 months, by using 2 questions and a human figure drawing illustrating the region as the space between the lower posterior margin of the rib cage and the horizontal gluteal fold. 2. Average pain in the last month at least 3 out of 10 on Numeric Rating Scale \[range 0 - 10, for 0 signifying no pain and 10 signifying worst pain imaginable\]. This level of pain allows comparability of the study results with the majority of cLBP studies. Pain rated less than 3 is too mild to detect improvement. 3. Men and women aged 18 years old and older. The investigators are not enrolling younger children as they are not part of the Intensive Pain Rehabilitation Therapy program. 4. Eligibility will be assessed using the following questions: "(1) How long has back pain been an ongoing problem for you? and (2) How often has low-back pain been an ongoing problem for you over the past 6 months?" A response of greater than three months to question 1, and a response of "at least half the days in the past 6 months" to question 2 would meet the cLBP eligibility criterion. 5. Ability to speak English. We do not have the capacity, given the resources available in this proposal, to translate all course material and conduct groups into another language. The investiagtors have previously enrolled Hispanic participants into other studies who were fluent in English, and expect to do this in the proposed study. 6. Owning a smart phone

Exclusion criteria

1. Unable to provide informed consent. 2. A substance abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential participant to participate or that may need immediate changes in medical management that will affect study outcome measures. Such conditions may include cancer, liver failure, renal failure, pain conditions from inflammatory diseases (e.g. rheumatoid arthritis, ankylosing spondylitis, lupus), malignancies or abdominal aortic aneurysm, muscle weakness from radiculopathy. Radiculopathy or sciatic pain is NOT excluded as long as the condition is stable and does not lead to significant movement restrictions or \<4/5 muscle weakness. Persons with significant substance abuse or mental health conditions that interfere with social functioning may be disruptive. Other medical or mental health conditions that need immediate changes in management need to be addressed before starting the study so that more reliable baseline measurements can be made. Patients who may need assessment for potentially necessary surgical interventions may not be able to complete the study. Regular opioid prescription is not an exclusion if stable over the past 3 months. 3. Spine related current or history of spine infection, spine tumor, vertebral fracture, cauda equina syndrome. Condition would increase heterogeneity of the sample. 4. Blindness, severe vision problems, deafness, severe hearing problems, bipolar or manic depression and not taking medication, major depression, psychoses (major), a substance abuse condition, dementia, unable to get up and down from the floor. Condition might make it difficult to participate. 5. Some other serious medical conditions that may alter key study outcomes, including untreated hypothyroidism, renal failure, and cirrhosis. Conditions that may alter key study outcomes. 6. Involvement in a lawsuit related to their back. Complicated medico-legal issues that could lead to individuals having a financial incentive to not report improvement. 7. Involved in Worker's Compensation claim. 8. Pregnant, breast-feeding, or planning to get pregnant in the next 12 months or less than 3 months post-partum. Particular back problems than may be associated with pregnancy and delivery may confound study outcomes. 9. Lack of stable housing or plan to move out of the area within the next 6 months. 10. MRI-related

Design outcomes

Primary

MeasureTime frameDescription
Pain Intensitybaseline, post 8-week interventionChange in average pain intensity in past week on Numeric Rating Scale \[0 to 10\] will be assessed by internet-based questionnaire using REDCap negative values indicate improvement.

Secondary

MeasureTime frameDescription
Pain Interferencebaseline, post 8-week interventionChange in average of the scores for the 3 Pain Interference items on PROMIS-29 \[5-point Likert scale from 1 "Not at all" to 5 "Very much"\] average for past week will be assessed by internet-based questionnaire using REDCap \[range 3 - 15, higher values more interference\] negative numbers indicate improvement in pain interference

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORWolf E Mehling, MD

University of California, San Francisco

Participant flow

Participants by arm

ArmCount
MBPR
Mindfulness-Based Pain Reduction
41
MBSR
Mindfulness-Based Stress Reduction
11
Total52

Baseline characteristics

CharacteristicMBPRMBSRTotal
Age, Continuous50.0 years
STANDARD_DEVIATION 12.1
58.4 years
STANDARD_DEVIATION 6.1
50.3 years
STANDARD_DEVIATION 12.7
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants0 Participants3 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
36 Participants11 Participants47 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants2 Participants
PEG score14.2 units on a scale
STANDARD_DEVIATION 5.5
16.6 units on a scale
STANDARD_DEVIATION 4.9
14.8 units on a scale
STANDARD_DEVIATION 5.6
Race (NIH/OMB)
American Indian or Alaska Native
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Asian
9 Participants4 Participants13 Participants
Race (NIH/OMB)
Black or African American
1 Participants1 Participants2 Participants
Race (NIH/OMB)
More than one race
2 Participants0 Participants2 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
2 Participants0 Participants2 Participants
Race (NIH/OMB)
White
26 Participants6 Participants32 Participants
Sex: Female, Male
Female
30 Participants10 Participants40 Participants
Sex: Female, Male
Male
11 Participants1 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 340 / 6
other
Total, other adverse events
1 / 340 / 6
serious
Total, serious adverse events
0 / 340 / 6

Outcome results

Primary

Pain Intensity

Change in average pain intensity in past week on Numeric Rating Scale \[0 to 10\] will be assessed by internet-based questionnaire using REDCap negative values indicate improvement.

Time frame: baseline, post 8-week intervention

ArmMeasureValue (MEAN)Dispersion
MBPRPain Intensity-2.30 score on a scaleStandard Deviation 2.5
MBSRPain Intensity-1.83 score on a scaleStandard Deviation 1.94
Secondary

Pain Interference

Change in average of the scores for the 3 Pain Interference items on PROMIS-29 \[5-point Likert scale from 1 Not at all to 5 Very much\] average for past week will be assessed by internet-based questionnaire using REDCap \[range 3 - 15, higher values more interference\] negative numbers indicate improvement in pain interference

Time frame: baseline, post 8-week intervention

ArmMeasureValue (MEAN)Dispersion
MBPRPain Interference-6.23 score on a scaleStandard Deviation 7.36
MBSRPain Interference-6.08 score on a scaleStandard Deviation 3.22
Other Pre-specified

Changes in Insula Cortex Activation/Connectivity; Awaiting Separate Analysis

using fMRI, insula cortex activation and connectivity in brain fMRI; awaiting separate analysis

Time frame: baseline, post 8-week intervention.

Other Pre-specified

Interoceptive Awareness

change in scores for the 8 scales of the Multidimensional Assessment of Interoceptive Awareness (MAIA-2) \[6-point 0-5 Likert scale Never to Always\] will be assessed by internet-based questionnaire using REDCap. Each scale range from 0-5, total score over all 8 scales is the mean of the score of the 8 scales, also ranges 0-5. Higher values indicate higher interoceptive awareness. positive values indicate improvement.

Time frame: baseline, post 8-week intervention

ArmMeasureValue (MEAN)Dispersion
MBPRInteroceptive Awareness0.76 score on a scaleStandard Deviation 0.61
MBSRInteroceptive Awareness0.61 score on a scaleStandard Deviation 0.69

Source: ClinicalTrials.gov · Data processed: Jul 17, 2026